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ABSTRACT  
Tremendous progress in synthetic micro/nanomotors has been made for potential biomedical applications. However, 
existing micro/nanomotor platforms are inefficient for deep tissue imaging and motion control in vivo. Here, we present 
a photoacoustic computed tomography (PACT) guided investigation of micromotors in intestines in vivo. The 
micromotors enveloped in microcapsules exhibit efficient propulsion in various biofluids once released. PACT has 
visualized the migration of micromotor capsules toward the targeted regions in real time in vivo. The integration of the 
developed microrobotic system and PACT enables deep imaging and precise control of the micromotors in vivo. 
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1. INTRODUCTION  
Micro and nanorobots that can be navigated into hard-to-reach tissues have drawn extensive attention for the promise to 
empower various biomedical applications, such as disease diagnosis, targeted drug delivery, and minimally invasive 
surgery [1-3]. Chemically powered motors, in particular, show great potential toward in vivo application thanks to their 
autonomous propulsion and versatile functions in bodily fluids [4-6]. However, imaging and control of micromotors in 
vivo remain major challenges for practical medical investigations, despite the significantly advanced development of 
micromotors [7-9]. The ability to directly visualize the dynamics of micromotors with high spatiotemporal resolution in 
vivo at the whole-body scale is in urgent demand to provide real-time visualization and guidance of micromotors [8]. In 
addition to high spatiotemporal resolution, the ideal non-invasive micromotor imaging technique should offer deep 
penetration and molecular contrasts. 
To date, optical imaging is widely used for biomedical applications owing to its high spatiotemporal resolution and 
molecular contrasts.[10-12] However, applying conventional optical imaging to deep tissues is hampered by strong 
optical scattering, which inhibits high-resolution imaging beyond the optical diffusion limit (~1–2 mm in depth) [13-15]. 
Fortunately, photoacoustic (PA) tomography (PAT), detecting photon-induced ultrasound, achieves high-resolution 
imaging at depths that far exceed the optical diffusion limit [16]. In PAT, the energy of photons absorbed by 
chromophores inside the tissue is converted to acoustic waves, which are subsequently detected to yield high-resolution 
tomographic images with optical contrasts. Leveraging the negligible acoustic scattering in soft tissue, PAT has achieved 
superb spatial resolution at depths, with a depth-to-resolution ratio of ~200 [12, 17], at high imaging rates. As a major 
incarnation of PAT, photoacoustic computed tomography (PACT) has attained high spatiotemporal resolution, deep 
penetration, and anatomical and molecular contrasts [18-22]. With all these benefits, PACT shows great promise for 
real-time navigation of micromotors in vivo for broad applications, particularly, drug delivery. Drug delivery through the 
gastrointestinal (GI) tract serves as a convenient and versatile therapeutic tool, owing to its cost-effectiveness, high 
patient compliance, lenient constraint for sterility, and ease of production [23]. Although oral administration of various 
micro/nanoparticle-based drug delivery systems has been demonstrated to both survive the acidic gastric environment 
and diffuse into the intestines, drug absorption is still inefficient due to the limited intestinal retention time [24]. A large 
number of passive diffusion-based targeting strategies have been explored to improve the delivery efficiency, but they 
suffer from low precision, size restraint and specific surface chemistry [25]. With precise control, microrobotic drug 
delivery systems can potentially achieve targeted delivery with long retention times and sustainable release profiles, 
which are in pressing need [26]. Due to the lack of imaging-guided control, there is no report yet for precisely targeted 
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delivery using micromotors in vivo [8]. Additionally, biocompatibility is required, and an ideal microrobotic system is 
expected to be cleared safely by the body after completion of the tasks [2]. 
In this paper, we describe a PACT-guided microrobotic system (PAMR), which has accomplished controlled propulsion 
and prolonged cargo retention in vivo. Owing to the high spatiotemporal resolution, non-invasiveness, molecular 
contrast, and deep penetration, PACT provides an attractive tool to locate and navigate the micromotors in vivo [27, 28]. 
Ingestible Mg-based micromotors are encapsulated in enteric protective capsules to prevent reactions in gastric acid and 
allow direct visualization by PACT. PACT monitors the migration of micromotor capsules (MCs) in intestines in real 
time; continuous-wave (CW) near-infrared (NIR) light irradiation induces phase transition of microcapsules and triggers 
propulsion of the micromotors; the autonomous and efficient propulsion of the micromotors enhances the retention in 
targeted areas of the GI tract. We believe that the proposed integrated microrobotic system will substantially advance 
gastrointestinal therapies. 
2. METHODS 
The fabrication of MCs mainly consists of two steps: the fabrication of Mg-based micromotors (Fig. 1a) and the 
formation of MCs (Fig. 1b). In the first step (Fig. 1a), Mg microparticles with a diameter of ~20 μm were dispersed onto 
glass slides, followed by the deposition of a gold layer, which facilitates the autonomous chemical propulsion in GI 
fluids and enhances PA contrast of the micromotors. An alginate hydrogel layer was coated onto the micromotors by 
dropping aqueous solution containing alginate and drugs (e.g., doxorubicin) on the slides. A parylene layer, acting as a 
shell scaffold that ensures the stability during propulsion, was then deposited onto the micromotors. A small opening (~2 
μm in diameter), attributed to the surface contact of the Mg microparticles with the glass slides during various layer 
coating steps, acts as a catalytic interface for gas propulsion in the intestinal environment. Next, the micromotors were 
encapsulated into the enteric gelatin capsules by the emulsion method (Fig. 1b).  
 
Figure 1. (a) The fabrication flow of the ingestible micromotors. (b) The preparation of the MCs. 
The green fluorescence from the fluorescein isothiocyanate-labeled bovine serum albumin (FITC-albumin) and red 
fluorescence from doxorubicin (DOX) were observed from the micromotors (Fig. 2, top row) and the MCs (Fig. 2, 
bottom row), confirming a successful drug loading.  
Proc. of SPIE Vol. 11240  112402R-2
Downloaded From: https://www.spiedigitallibrary.org/conference-proceedings-of-spie on 19 Feb 2020






Figure 2. Fluorescence images of the micromotors (top row) and the MCs (bottom row), confirming the successful drug 
loading. Scale bar, 20 µm. 
For deep tissue imaging in vivo, it is crucial that the MCs should have higher optical absorption than the blood 
background. To evaluate the PA imaging performance of the MCs, the PA amplitudes of the MCs, whole blood, and bare 
Mg particles were measured. NIR light experiences the least attenuation in mammalian tissues, permitting the deepest 
optical penetration. As shown in Fig. 3a, the MCs exhibit strong PA contrast in the NIR wavelength region, ranging 
from 720 to 890 nm. At the wavelength of 750 nm, the MCs display the highest PA amplitude of 15.3 (Fig. 3a). The 
bare Mg particles display a similar PA spectrum, with a lower PA peak with an amplitude of 10.0 at 750 nm. The 
difference due to the Au layer is expected to significantly improve the imaging sensitivity in the NIR wavelength region 
(Fig. 3a) [29-31]. In addition, the approximate 3-fold increase in PA amplitudes of the MCs compared to that of the 
whole blood provides sufficient contrast for PACT to detect the MCs in vivo using 750-nm illumination. To evaluate the 
stability of the MCs under pulsed NIR PA excitation, we measured the PA signal fluctuation of the MCs during PA 
imaging (Fig. 3b). We also studied the maximum detectable depth of MCs using PACT (Fig. 3c). The micromotors 
showed dramatically decreased fluorescence intensity when covered by thin tissues (0.7–2.4 mm in thickness) and 
became undetectable quickly (Fig. 3c, inset). By contrast, PACT can image the micromotors inside tissue as deep as ~7 
cm (Fig. 3c), which reveals that the key advantage of PACT lies in the high spatial resolution and high molecular 
contrast for deep imaging in tissues [18]. 
 
Figure 3. Characterization of the MCs. (a) PACT spectra of MCs (red line), blood (blue line), and Mg particles (black 
line). (b) Long-term stability of the PA signals of the MCs under the NIR illumination used in the PACT. Error bars 
represent the SDs from 5 independent measurements. (c) Dependence of PA amplitude of the MCs (red line) and blood 
(black line) on the depth of tissue and the normalized PA amplitude and fluorescence intensity of the MCs under tissues 
(inset). Norm., normalized; amp., amplitude; Fl., fluorescence; int., intensity. Error bars represent the SDs from five 
independent measurements. 
3. RESULTS 
The movement of a swarm of MCs was monitored in vivo by PACT. The MCs were dispersed in pure water and then 
orally administered into 5–6-week old nude mice. The mice were subsequently anesthetized, and the lower abdominal 
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cavity was aligned with the imaging plane of the ultrasonic transducer array for longitudinal imaging. PACT images 
were captured at a frame rate of 2 Hz for ~8 hours. As shown in Fig. 4a, where the blood vessels and background tissues 
are shown in gray and MCs in intestines are highlighted in color. During the imaging period of the first 6 hours, the MCs 
migrated for ~1.2 cm, roughly 15% of the length of the entire small intestine. After 5 hours, the PA signals of some MCs 
faded away as they moved downstream in intestines that were outside of the imaging plane. The moving speed of the 
swarm MCs in the intestines and the movements induced by respiratory motion were quantified (Fig. 4b–d). As shown 
in Fig. 4b–d, the abrupt motion caused by respiration is much faster than the actual migration of the MCs. Despite the 
respiration-induced movement, PACT can distinguish the signals from the slowly migrating MCs in the intestines. These 
results indicate that PACT can precisely monitor and track the locations of the MCs in deep tissues in vivo. 
 
Figure 4. PACT evaluation of the MCs dynamics in vivo. (a) A representative PACT image of the MCs in intestines in 
vivo. The MCs migrating in the intestine are shown in color; the mouse tissues are shown in gray. Scale bar, 2 mm. (b) 
The thresholded x-t image showing the segmented MCs at elapsed time. (c) The movement displacement caused by the 
migration of the MCs in intestines. (d) Comparison of the speeds of the MC migration and the respiration-induced 
movement. Error bars represent the SDs from three independent measurements. 
Of particular biomedical significance is the retention of cargo carriers in the targeted region in intestines. While most of 
the previous studies focused on improving the interactions between particles and the mucoadhesives by engineering 
surface coatings on the passive particles, the biofluid-driven propulsion of the active micromotors can dramatically 
prolong their retention in intestine walls. When the MCs approach the targeted areas in intestines, we can trigger the 
collapse of the capsules and activate the propulsion of micromotors on demand (Fig. 5a). Once the MCs approach the 
targeted location, they are irradiated with CW NIR light to trigger a responsive release of the micromotors. The PA 
signals from the MCs in the intestines were prolonged upon the CW NIR irradiation, suggesting the release of the 
micromotors (Fig. 5b). Besides the active propulsion, the enhanced retention in vivo may also be attributed to the 
elevated pH and Mg2+ concentration in the surrounding environment caused by Mg-water reactions. It has been recently 
reported that high pH (~8.2–12.0) could trigger a phase transition of the mucus and facilitate tissue penetration of the 
micro/nanoparticles [32]. To investigate the influence of the micromotors on the pH of the surrounding environment, the 
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micromotors were dispersed in water with phenolphthalein as a pH indicator. The microscopic image in Fig. 5c shows 
red/orange color in the vicinity of a micromotor, indicating an increased pH of the surrounding medium.  
 
Figure 5. Evaluation of the MCs for targeted retention and delivery. (a) Schematic of the use of the MCs for targeted 
delivery in intestines. (b) Microscopic images showing the propulsion of the micromotor in intestinal fluid after CW NIR 
triggered release. Scale bar, 20 μm.  (c) Microscopic image displaying the change of pH of the surrounding environment 
upon the micromotors in PBS. 
4. DISCUSSION 
Two key challenges should be addressed for applying synthetic micromotors to practical biomedical applications: 1) 
advanced imaging techniques to locate micromotors in deep tissue at high spatiotemporal resolution with high contrast; 
2) precise on-demand control of micromotors in vivo. With high molecular sensitivity at depths, PACT allows real-time 
monitoring of micromotors in intestines at high spatial resolution for subsequent control. Here, micromotors with partial 
coating of functional multilayers are designed as both the imaging contrast agents and the controllable drug carriers. An 
Au layer is employed to significantly increase the optical absorption for PA imaging and the reaction rate for efficient 
propulsion simultaneously. A gelatin hydrogel layer is used to enlarge the loading capacity of different functional 
components, such as therapeutic drugs and imaging agents. A parylene layer is applied to maintain the geometry of the 
micromotors during propulsion. Our current platform, integrating real-time imaging and control of micromotors in 
intestines in vivo, leads to the next generation of intelligent microrobotic systems, and provides opportunities for precise 
microsurgery and targeted drug delivery.  
Although the current platform has been demonstrated in small animals, human clinical translations may require tens of 
centimeters of tissue penetration. PACT can provide up to 7-cm tissue penetration, which is limited by photon 
dissipation [21, 33]. By employing a more penetrating excitation source—microwave and acoustic detection, 
thermoacoustic tomography (TAT) promises tissue penetration for clinical translations [34]. Moreover, incorporation of 
a gold layer in the micromotor design provides an excellent microwave absorption contrast for TAT owing to the high 
electrical conductivity, and thus greatly enhances the deep tissue imaging capability of the microrobots for clinical 
applications. Focused ultrasound heating can increase the depths of thermally triggered microrobot release to the whole-
body level of humans. Currently, the passive diffusion-based delivery suffers from complex designs, particle size 
constraints, low precision, and poor specificity. Our platform allows micromotors to reach any targeted regions in 
intestines with high precision. It can be tailored to particles of any sizes and can be applied to any biological media 
without additional design efforts. Our platform can also be easily modified to carry various cargos, including therapeutic 
agents and diagnostic sensors, with real-time feedback during delivery. Biocompatibility and biodegradability of the 
micromotors are essential for practical biomedical applications. The components of our micromotors, widely used as 
therapeutic agents and in implantable devices, are studied to be safe for in vivo applications [35]. The micromotors have 
been eventually cleared by the digestive system via excrement, without any adverse effects. 
In summary, we report an ingestible microrobotic platform with high optical absorption for imaging-assisted control in 
intestines. The encapsulated micromotors survive the erosion of the stomach fluid and permit propulsion in intestines. 
PACT non-invasively monitors the migration of the micromotors and visualizes their arrival at targeted areas in vivo. 
CW NIR irradiation toward targeted areas induces a phase transition of the capsules and triggers the propulsion of the 
micromotors. The mechanical propulsion provides a driving force for the micromotors to bind to the intestine walls, 
resulting in an extended retention. The proposed platform lays a foundation for targeted delivery in tissues and opens a 
new horizon for precision medicine. 
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